刊名:Urologic Oncology: Seminars and Original Investigations
出版年:2017
出版时间:February 2017
年:2017
卷:35
期:2
页码:38.e9-38.e15
全文大小:436 K
卷排序:35
文摘
The first study to report that GC adjuvant chemotherapy is a safe conservative treatment for T1G3 bladder cancer. Patients with T1G3 tumor concomitant CIS should be treated more aggressively because of the high risk of progression. We are expecting a further validation in a larger population.